Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

Metalloproteinases (MMPs) are implicated in neointima formation and hence vein graft failure. Gene transfer to elevate local levels of tissue inhibitor of metalloproteinases (TIMPs) is therefore a potential treatment. In this study, we have used lumenal application of a replication-defective recombinant adenovirus to overexpress TIMP-2 and observe the effects on neointimal thickening in a well characterised human saphenous vein organ culture model. Increased TIMP-2 expression was localised to lumenal surface cells but nevertheless increased total functional TIMP-2 secretion after 14 days culture from 4.0 ± 2.0 to 21.8 ± 2.9 ng/mg wet weight/day (P < 0.05, n = 3). in situ zymography revealed a marked inhibition of gelatinolytic activity by timp-2 gene transfer throughout the vein segments. neointima formation and neointimal cell numbers were reduced 79% and 71%, respectively (p < 0.05; n = 8). timp-2 overexpression had no effect on smooth muscle cell proliferation, secretion of pro-mmp-2 or -9 and did not inhibit the processing of pro-mmp-2 to its active form. our data indicate that timp-2 overexpression reduces neointimal thickening, primarily by inhibiting mmp activity and hence smooth muscle cell migration.